Evolution Research Group Acquires Finger Lakes Clinical Research.
M2 EQUITYBITES-April 3, 2019-Evolution Research Group Acquires Finger Lakes Clinical Research
(C)2019 M2 COMMUNICATIONS http://www.m2.com
3 April 2019 - New Jersey, US-based clinical research site Evolution Research Group (ERG) has acquired New York-based Finger Lakes Clinical Research (FLCR), specialising in pediatric and adult central nervous system trials for pharmaceutical firms, the company said.
Terms of the transaction were not disclosed.
ERG said the addition of FLCR expands ERG's geographic capabilities in both adult and pediatric outpatient trials and further enhances ERG's growing service offerings.
Evolution Research Group, LLC, backed by Linden Capital, is an independent clinical research site company serving pharmaceutical companies and clinical research organisations, with an expertise in early- and late-stage neuroscience drug development.
Evolution Research Group is comprised of 13 wholly owned and operated clinical research units, and an established network of affiliated clinical research sites.
Linden Capital Partners is a Chicago-based private equity firm focussed exclusively on investing in the healthcare industry.
FLCR has conducted trials across a broad range of illnesses, including anxiety disorders, ADHD, depression, bipolar disorder, schizophrenia and other mental illnesses since its founding in 2002.
Honigman LLP and Kirkland and Ellis LLP served as legal advisors to ERG.
Fried Frank served as legal advisors to FLCR.
((Comments on this story may be sent to firstname.lastname@example.org))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Apr 3, 2019|
|Previous Article:||Evolve IP Acquires Speech Analytics Firm Jog.ai.|
|Next Article:||Encompass Health to Acquire Assets of Alacare Home Health/Hospice.|